RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Mark Levi RTI Expert Headshot

Mark Levi

Director of Regulatory Affairs


PhD, Medicinal Chemistry, University of Mississippi
BS, Chemistry, Harding University


Mark Levi is an expert in biopharma regulatory affairs with passion for U.S. regulatory strategy and international harmonization. He is an expert in biologics, cell therapy, monoclonal antibodies, vaccines, gene therapy, pharmacology, data integrity, biologic-device combination products, neurotoxicology, and regulatory and product development strategy.

Dr. Levi joined RTI in 2022. Prior, he served as an FDA reviewer and regulatory project manager. He was also a director of regulatory affairs at a late-stage biotech industry and a senior consultant at a large contract research organization. In addition to his work, Dr. Levi has professional affiliations with the New Zealand Institute of Chemistry and the Regulatory Affairs Professionals Society (RAPS).

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics